Abstract #1722

Development of an evaluation system for analgesic drugs targeted to allodynia-specific pain using BOLD fMRI

Naoya Yuzuriha¹, Sosuke Yoshinaga¹, Hiroshi Sato², Sokichi Honda³, Keisuke Tamaki³, Toshihiro Sekizawa³, Akihiko Fujikawa³, and Hiroaki Terasawa¹

¹Department of Structural BioImaging, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan, ²Bruker Biospin K.K., Yokohama, Japan, ³Drug Discovery Research, Astellas Pharm. Inc., Tsukuba, Japan

The aim of this study is to evaluate the analgesic effect of pregabalin on allodynia-specific pain. fMRI images of fibromyalgia model rats were acquired, before and after pregabalin administration. When treated with saline, the BOLD signal intensities in the S1, IC, and TH were increased upon the laser stimulation by up to 1.7%, 1.3%, and 1.8%, respectively. In contrast, in the pregabalin treated rats, no BOLD responses were detected. It is conceivable that the pain signals were inhibited by pregabalin, and thus the stimulation-induced BOLD responses were not observed. We successfully observed the suppression of allodynia-specific pain responses by pregabalin.

How to access this content:

For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.

After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.

After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.

Click here for more information on becoming a member.